<code id='165472AA2D'></code><style id='165472AA2D'></style>
      • <acronym id='165472AA2D'></acronym>
      <center id='165472AA2D'><center id='165472AA2D'><tfoot id='165472AA2D'></tfoot></center><abbr id='165472AA2D'><dir id='165472AA2D'><tfoot id='165472AA2D'></tfoot><noframes id='165472AA2D'>
      • <optgroup id='165472AA2D'><strike id='165472AA2D'><sup id='165472AA2D'></sup></strike><code id='165472AA2D'></code></optgroup>
        5. <b id='165472AA2D'><label id='165472AA2D'><select id='165472AA2D'><dt id='165472AA2D'><span id='165472AA2D'></span></dt></select></label></b><u id='165472AA2D'></u>
          <i id='165472AA2D'><strike id='165472AA2D'><tt id='165472AA2D'><pre id='165472AA2D'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-09-28 11:10:08 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：hotspot   
                                        
                                      
                                      Page View：17873
                                  
                                    
          
                                   
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. 																									Ruby Wallau for STAT
          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.
          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.
          advertisement
          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Readout LOUD podcast: Live from the 2023 STAT Summit
                                
                            
          Next article：  
                                      
                                          Medicare details structure of new drug price negotiation program
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles